Loading clinical trials...
Loading clinical trials...
The primary objective is to investigate the ability of systemic intravenous antibiotic plus antibiotic/anti-biofilm (i.e. N-acetylcysteine) lock catheter technique in eradicating uncomplicated cathete...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
University of California, San Diego
NCT04634916 · Kidney Disease, End-Stage, End-stage Renal Disease, and more
NCT06933472 · Hyperphosphatemia, Chronic Kidney Disease, Receiving Dialysis, and more
NCT07224763 · ESRD (End-Stage Renal Disease), Kidney Transplantation, and more
NCT07033260 · Intradialytic Hypotension, End-Stage Renal Disease Requiring Haemodialysis, and more
NCT05738525 · End-stage Renal Disease
Ben Taub General Hospital
Houston, Texas
Michael E. DeBakey VA Medical Center
Houston, Texas
The Methodist Hospital
Houston, Texas
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions